Genomic alterations, including somatic mutations, homozygous deletions, and amplifications in the TGF-β signaling pathway, were found in 39% of 9125 tumor samples across 33 cancer types in the Cancer Genome Atlas (TCGA) [16]. The gene discussed is TGFB1; the disease is neoplasm.